BioSpace News Archive

Neovasc Announces Consolidation and Extension of Convertible Debt

Neovasc Inc. announced that, pursuant to a Restated Securities Purchase Agreement with Strul Medical Group LLC, on a private placement basis, it has issued an amended and restated convertible note.

March 24, 2022
·
9 min read
BioMidwest

New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion SystemStudy published in the IJSS shows Surgalign product to be a reliable solution for SIJ dysfunction

Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced the publication of results from EVoluSIon (EVSI), a large, prospective, multi-center study of clinical outcomes following minimally invasive sacroiliac joint (SIJ) fusion with decortication.

March 24, 2022
·
5 min read
Pharm Country

SK life science to Present Latest XCOPRI® (cenobamate tablets) CV Data at the American Academy of Neurology 2022 Annual Meeting

SK life science will share four posters and two oral presentations on its anti-seizure medication (ASM) cenobamate.

March 24, 2022
·
11 min read
Job Trends

Abbott’s FreeStyle® Libre is First and Only CGM System to Gain Expanded Reimbursement in Japan to Include All People with Diabetes Who Use Insulin

Abbott (NYSE: ABT) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the expansion of reimbursement coverage for its FreeStyle® Libre system to include all people with diabetes who use insulin at least once a day.

March 24, 2022
·
3 min read
INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting

INVO Bioscience, Inc. is exhibiting the INVOcell solution at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting, taking place March 23-27 at the Renaissance Esmeralda Resort & Spa.

March 24, 2022
·
3 min read
Pharm Country

Gilgamesh Announces Clinical Candidates For Two Programs With First In Human Dosing to Begin in Late 2022

Gilgamesh Pharmaceuticals today announced the nomination of two lead clinical candidates for the treatment of debilitating neuropsychiatric disorders such as depression, anxiety, PTSD, and substance use disorders.

March 24, 2022
·
2 min read
Genetown

Precision Optics Announces Receipt of $2.5 Million Production Orders from Large Medical Device Company for Spinal Surgery Application

Precision Optics Corporation, Inc. (OTCQB: PEYE), today announced the receipt of multiple production orders totaling approximately $2.5 million from a large medical device company to meet increased demand for the customer’s spinal surgery product that utilizes Precision Optics proprietary illumination technology.

March 24, 2022
·
4 min read
Business

Miruna Sasu, Former Johnson & Johnson Executive, Takes the Helm at COTA, Inc. as President and CEO

COTA, Inc. , an oncology real-world data and analytics company, announced today that Miruna Sasu , Ph.D. MBA, has been appointed president and chief executive officer.

March 24, 2022
·
4 min read
Business

Jennifer Rubio, co-founder and CEO of Away, joins the Board of Directors at Scripps Research

Entrepreneur and philanthropist Jennifer Rubio has been named to the Board of Directors at Scripps Research.

March 24, 2022
·
2 min read
Business

LivaNova to Announce First-Quarter 2022 Results

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first-quarter 2022 results on Wednesday, May 4, 2022 at 1 p.m. London time (8 a.m. EDT).

March 24, 2022
·
2 min read